Annika Ålgars

1.1k total citations
34 papers, 657 citations indexed

About

Annika Ålgars is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Annika Ålgars has authored 34 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Annika Ålgars's work include Colorectal Cancer Treatments and Studies (18 papers), Genetic factors in colorectal cancer (12 papers) and Gastric Cancer Management and Outcomes (9 papers). Annika Ålgars is often cited by papers focused on Colorectal Cancer Treatments and Studies (18 papers), Genetic factors in colorectal cancer (12 papers) and Gastric Cancer Management and Outcomes (9 papers). Annika Ålgars collaborates with scholars based in Finland, Sweden and Norway. Annika Ålgars's co-authors include Raija Ristamäki, Jari Sundström, Sirpa Jalkanen, Olli Carpén, Heikki Irjala, Marko Salmi, Heikki Huhtinen, Minnamaija Lintunen, Samuli Vaittinen and Yrjö Collan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Annika Ålgars

30 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annika Ålgars Finland 14 393 185 161 147 122 34 657
Che Xiangming Japan 14 578 1.5× 454 2.5× 162 1.0× 343 2.3× 151 1.2× 24 1.1k
Kshitij S. Arora United States 13 254 0.6× 59 0.3× 113 0.7× 284 1.9× 176 1.4× 37 684
Nuria Kotecki Belgium 13 324 0.8× 101 0.5× 284 1.8× 137 0.9× 59 0.5× 68 592
Haruhisa Kitano Japan 11 213 0.5× 166 0.9× 109 0.7× 263 1.8× 67 0.5× 16 547
Yongkui Lu China 11 350 0.9× 51 0.3× 259 1.6× 220 1.5× 92 0.8× 20 657
Youyou Xia China 14 349 0.9× 48 0.3× 208 1.3× 227 1.5× 106 0.9× 27 633
Marco Losa Switzerland 11 456 1.2× 48 0.3× 242 1.5× 334 2.3× 107 0.9× 20 812
Lucy Ireland United Kingdom 10 516 1.3× 408 2.2× 138 0.9× 353 2.4× 71 0.6× 15 993
Chuntao Wu China 16 431 1.1× 155 0.8× 116 0.7× 193 1.3× 96 0.8× 30 686
Junjie Hang China 12 354 0.9× 222 1.2× 108 0.7× 227 1.5× 81 0.7× 31 634

Countries citing papers authored by Annika Ålgars

Since Specialization
Citations

This map shows the geographic impact of Annika Ålgars's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annika Ålgars with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annika Ålgars more than expected).

Fields of papers citing papers by Annika Ålgars

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annika Ålgars. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annika Ålgars. The network helps show where Annika Ålgars may publish in the future.

Co-authorship network of co-authors of Annika Ålgars

This figure shows the co-authorship network connecting the top 25 collaborators of Annika Ålgars. A scholar is included among the top collaborators of Annika Ålgars based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annika Ålgars. Annika Ålgars is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Österlund, Pia, Timo Muhonen, Emerik Österlund, et al.. (2025). Relapse patterns, risk factors, re-resectability and survival after curative treatment for metastatic colorectal cancer (mCRC): A RAXO substudy.. Journal of Clinical Oncology. 43(16_suppl). 3566–3566.
2.
Lapela, Maria, et al.. (2024). Determination of effective half-life of 131I in thyroid cancer patients using remote dose-rate meter. EJNMMI Physics. 11(1). 101–101.
4.
Minn, Heikki, et al.. (2023). Short-course preoperative radiotherapy increases pelvic fracture risk in rectal cancer. Clinical and Translational Radiation Oncology. 42. 100656–100656. 3 indexed citations
5.
Heervä, Eetu, Ari Ristimäki, Soili Kytölä, et al.. (2023). PD-19 Finnish population-based metastatic colorectal cancer data collection study – comparison with the prospective RAXO study. Annals of Oncology. 34. S8–S9.
8.
Heervä, Eetu, Tapio Salminen, Samu Kurki, et al.. (2020). An easily adaptable validated risk score predicts cancer-specific survival in stage II colon cancer. Acta Oncologica. 59(12). 1503–1507. 3 indexed citations
9.
Österlund, Pia, Tapio Salminen, Annika Ålgars, et al.. (2019). Patient characteristics associated with poor performance status, ECOG 2-3, and effect on survival in 1086 Finnish metastatic colorectal cancers (mCRC) nationwide (prospective RAXO study). Annals of Oncology. 30. v245–v245. 1 indexed citations
11.
Mansuri, Naziha, Samu Kurki, Annika Ålgars, et al.. (2017). Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 472(3). 369–382. 51 indexed citations
13.
Irjala, Heikki, Tuomas Mirtti, Pekka Taimen, et al.. (2015). Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer. PLoS ONE. 10(7). e0133552–e0133552. 54 indexed citations
14.
Ålgars, Annika, Pia Österlund, Minnamaija Lintunen, et al.. (2014). Heterogeneous EGFR Gene Copy Number Increase Is Common in Colorectal Cancer and Defines Response to Anti-EGFR Therapy. PLoS ONE. 9(6). e99590–e99590. 17 indexed citations
15.
Ålgars, Annika, M. Lintunen, Olli Carpén, Raija Ristamäki, & Jari Sundström. (2011). EGFR gene copy number assessment from areas with highest EGFR expression predicts response to anti-EGFR therapy in colorectal cancer. British Journal of Cancer. 105(2). 255–262. 40 indexed citations
16.
Ålgars, Annika, Heikki Irjala, Samuli Vaittinen, et al.. (2011). Type and location of tumor‐infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients. International Journal of Cancer. 131(4). 864–873. 125 indexed citations
17.
Buhmeida, Abdelbaset, Adam Elzagheid, Annika Ålgars, et al.. (2008). Expression of the cell‐cell adhesion molecule β‐catenin in colorectal carcinomas and their metastases. Apmis. 116(1). 1–9. 16 indexed citations
18.
Bendardaf, Riyad, Adam Elzagheid, Hanan Lamlum, et al.. (2006). Thymidylate synthase expression in primary colorectal tumours is correlated with its expression in metastases. Scandinavian Journal of Gastroenterology. 42(4). 471–476. 7 indexed citations
19.
Buhmeida, Abdelbaset, Annika Ålgars, Raija Ristamäki, et al.. (2006). DNA Image Cytometry Is a Useful Adjunct Tool in the Prediction of Disease Outcome in Patients with Stage II and Stage III Colorectal Cancer. Oncology. 70(6). 427–437. 7 indexed citations
20.
Bendardaf, Riyad, H. Lamlum, Raija Ristamäki, et al.. (2004). Response to Chemotherapy (Irinotecan plus 5-Fluorouracil) in Colorectal Carcinoma Can Be Predicted by Tumour DNA Content. Oncology. 66(1). 46–52. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026